companies: 6,640     total market cap: $98.43 T
BELLUS Health Inc.
BLU

$1.87 B
Marketcap
$14.75
Share price
CA
Country
$0.01
Change (1 day)
$14.76
Year High
$6.38
Year Low
Biotechnology
Categories

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.

marketcap

Stock price history for BELLUS Health Inc. (BLU)

Highest end of day price: $747.36 USD on 2005-03-08

Lowest end of day price: $0.61 USD on 2016-08-01

Stock price history of BELLUS Health Inc. from 2003 to 2023


What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

Stock prices are delayed, the delay can range from a few minutes to several hours. MarketCap.tools is not a Financial institution.

Contact

For inquiries or if you want to report a problem write to web@marketcap.tools

© 2023 Marketcap.tools